نتایج جستجو برای: درمان haart

تعداد نتایج: 47583  

Journal: :Revista da Associacao Medica Brasileira 2017
Farnoosh Peykanpour Sadra Ansaripour Milad Ebrahimi

INTRODUCTION The Brazilian HIV/AIDS management and treatment guideline (PCDT), published in 2013, recommends and standardizes the use of highly active antiretroviral therapy (HAART) in all adult patients, in spite of LTCD4 count. This study aimed to analyze the first year of HAART use in patients from a reference center on HIV/AIDS management in Fortaleza, Ceará. METHOD This descriptive study...

2014
Claudia Palladino Verónica Briz José María Bellón Francisco J. Climent Santiago J. de Ory María José Mellado María Luisa Navarro José T. Ramos Nuno Taveira María Isabel de José María Ángeles Muñoz-Fernández

OBJECTIVES To investigate the duration of sequential HAART regimens and predictors of first-line regimen discontinuation among HIV-1 vertically infected children and adolescents. DESIGN Multicentre survey of antiretroviral-naïve patients enrolled in the HIV-Paediatric Cohor,t CoRISpeS-Madrid Cohort, Spain. METHODS Patients with a follow-up of ≥ 1 month spent on HAART, with available baselin...

Journal: :Perspectives on sexual and reproductive health 2006
Eric Rice Philip Batterham Mary Jane Rotheram-Borus

CONTEXT Since the advent of highly active antiretroviral therapy (HAART) in 1996, the incidence of HIV-especially among young men who have sex with men-and the prevalence of unprotected sex among HIV-positive persons have increased. The characteristics associated with unprotected sex among youth living with HIV since the advent of HAART have not been explored. METHODS Samples of HIV-positive ...

Journal: :Journal of immunology 2006
Zheng Zhang Junliang Fu Qingxia Zhao Yun He Lei Jin Hui Zhang Jinxia Yao Linqi Zhang Fu-Sheng Wang

Numerical and functional deficits in myeloid (mDC) and plasmacytoid dendritic cell (pDC) subsets have been found in both adult and pediatric HIV-1 carriers. Whether these impaired DC subsets can be restored after treatment with highly active antiretroviral therapy (HAART) is currently unknown, especially in HIV-1-infected children. In this report, we characterized mDC and pDC subsets in 18 HIV-...

Journal: :Current HIV research 2007
Yvonne Lim Ai Lian Benedict Sim Lim Heng Veeranoot Nissapatorn Christopher Lee

Attempts to address the significant impact of HAART on medical variables on the Malaysian HIV/AIDS population have yet to be evaluated. This study aims to analyze the proportions of AIDS-defining illnesses (ADIs) before and after HAART. A retrospective study was carried out on 128 new cases of HIV infected patients who first commenced HAART in 2004 at the national HIV reference center. Before c...

2018
Yee Shan Low Farida Islahudin Kamarul Azahar Mohd Razali Shafnah Adnan

Background Treatment options among Human Immunodeficiency Virus (HIV)-infected children are limited as only a few Highly Active Antiretroviral Therapy (HAART) are approved worldwide for paediatric use. Among children, frequent changes in HAART regimen can rapidly exhaust treatment options, and information addressing this issue is scarce. Objective The aim of the study was to determine factors...

Journal: :Revista chilena de infectologia : organo oficial de la Sociedad Chilena de Infectologia 2006
Laura Bahamondes M M José Villar Z Carolina Orellana C Jimena González R Cristian Montenegro U

Highly active antiretroviral therapy (HAART) has changed the epidemiology of Pneumocystis jiroveci pneumonia (PCP) in AIDS patients. Global incidence of PCP has decreased and now it is prevalent in AIDS patients who do not receive HAART or are unsuccessfully treated with persistent immune depression. Moreover, the immunologic response to HAART has caused a PCP form which is included in the immu...

Journal: :Annals of oncology : official journal of the European Society for Medical Oncology 2004
G Toffoli G Corona G Cattarossi M Boiocchi G Di Gennaro U Tirelli E Vaccher

BACKGROUND We demonstrated that highly active antiretroviral therapy (HAART) increases the toxic effect of cyclophosphamide, vincristine, doxorubicin (DOX) and prednisone (CHOP) in HIV-patients with non-Hodgkin's lymphoma (NHL). To ascertain the cause of increased toxicity, we investigated the pharmacokinetics of DOX in HIV-patients with NHL treated with CHOP with and without HAART. METHODS C...

Journal: :Journal of Immune Based Therapies and Vaccines 2006
Kenneth H Huang Marie-Pierre Boisvert Famane Chung Maude Loignon Don Zarowny Lise Cyr Emil Toma Nicole F Bernard

BACKGROUND Despite the benefits of highly active antiretroviral therapy (HAART) for suppressing viral replication in HIV infection, virus persists and rebounds during treatment interruption (TI). This study explored whether HAART intensification with Remune vaccination before TI can boost HIV-1-specific immunity, leading to improved control of viremia off HAART. METHODS Ten chronically HIV-in...

2015
Adebayo L Adedeji Theophilus L. Olawoye

Association between reduced serum alpha-1 antitrypsin (α1AT) concentration and HIV infection has been reported. The possible role of α1AT in a subset of people living with HIV who achieved control over HIV-1 disease progression without treatment has not been substantiated. We thus hypothesized that increased serum concentrations of α1AT would be associated with control of HIV disease progressio...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید